CN104435133A - 一种退烧药 - Google Patents
一种退烧药 Download PDFInfo
- Publication number
- CN104435133A CN104435133A CN201410716229.5A CN201410716229A CN104435133A CN 104435133 A CN104435133 A CN 104435133A CN 201410716229 A CN201410716229 A CN 201410716229A CN 104435133 A CN104435133 A CN 104435133A
- Authority
- CN
- China
- Prior art keywords
- fever
- febrifuge
- water
- medicament
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 206010037660 Pyrexia Diseases 0.000 title abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 239000006187 pill Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000007924 injection Substances 0.000 claims abstract description 7
- 238000002347 injection Methods 0.000 claims abstract description 7
- 239000002552 dosage form Substances 0.000 claims abstract description 4
- 239000003826 tablet Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 229940079593 drug Drugs 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000002893 slag Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 3
- 206010022000 influenza Diseases 0.000 abstract description 13
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 13
- 210000004243 sweat Anatomy 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 235000015700 Artemisia abrotanum Nutrition 0.000 abstract 1
- 244000249062 Artemisia abrotanum Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- -1 decoction Substances 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000036760 body temperature Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229960001361 ipratropium bromide Drugs 0.000 description 2
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种退烧药,是以柴胡、生甘草、黄芩、连翘、青蒿为原料制成的药剂,该药物可以被加工成汤剂、片剂、丸剂、散剂、胶囊剂、针剂等剂型。本发明的退烧药具有解表、散节、清火、祛潮热,令邪气散去而正气无伤,助五脏中热气更快、更充分的排出。经400例患者临床治疗观察,该中药能够短时间对急发性发热进行治愈,零复发,疗程短,无毒副作用,对普通感冒引起的发热,退烧的总有效率可达99%,对流行感冒引起的发热,退烧的总有效率可高达98%。
Description
技术领域
本发明属于中药治疗疾病领域,特别是涉及一种退烧药用于治疗急性发热。
背景技术
感冒时,体温常常达38.5°以上,一般有汗出热不退或无汗身热者两种状态,多数患者会采用服用退烧药或挂水。退烧药是一种可以通过调节人体机能使人体体表血管扩张、进而借助于出汗等过程使散热增加,同时抑制寒战、使机体产热减少的药品。但退烧药多伴有毒副作用,如药疹、胃肠道反应、血液系统反应及对肝肾功能的损害等,尤其是当久用或过量使用此类药物时,毒副作用更加显著。
中医认为感冒发烧,是因五脏调理五气产生体能而生体温,若五脏调理五气,热不能排,为皮肤毛孔被风、暑、寒、湿、燥火之气闭塞,即肺金毛孔收敛(肺主皮毛),致体温、热气无法从皮肤毛孔排出。目前,中医退烧的方子很多,质量参差不齐,疗效相差甚远。
发明内容
为了解决现有技术中存在的诸多不足,本发明公开了一种退烧药,具有疗效短、见效快、无毒副作用、经济实用、治愈率高等优点。
本发明的退烧药,是由以下重量配比的原料制成的药剂:柴胡6~10,生甘草1~3,黄芩2~5,连翘8~12,青蒿3~9。
作为一种优选实施方式,其中各原料的重量配比是:柴胡8,生甘草2,黄芩3,连翘10,青蒿6。
作为一种优选实施方式,其中各原料的重量配比是:柴胡8,生甘草3,黄芩3,连翘11,青蒿7。
上述中药原料所述的药剂是任何一种药剂学上所说的剂型,如制成口服或注射药剂,即药剂学上所述的汤剂、片剂、丸剂、散剂、胶囊剂、针剂等。
本发明药物剂型的具体制备方法如下:
称取上述重量配比的各原料药,用水冲洗干净,加水煎煮2~4次,每次煎煮加入原料药总重量5~12倍的水,煎煮15~20分钟,合并每次的煎液,经过滤去渣装包,即得到汤剂;将过滤后的煎液经浓缩成相对密度1.15~1.30(50℃)的稠膏,干燥、粉碎成细粉得到散剂,装入胶囊中制成胶囊剂;添加制丸剂的常规辅料得到丸剂;添加制片剂的常规辅料得到片剂;添加冻干粉得到针剂。
本发明中柴胡味苦、性寒、性升而发散,与黄芩配伍具有退热、解往来寒热之效,再加上青蒿、生甘草的辅助,四味中药药性相互牵制与促进,能够达到解表退潮热,升阳益气之功效;连翘味苦辛、性寒、入心、胆、三焦、大肠经,善清泄少阳之火,与甘草、黄芩配伍,可入心、肺、胆、三焦、大肠、小肠进行解表散热,清火散结效果更佳;黄芩与连翘、柴胡配伍使体内热气更容易外排,达到散热的目的;甘草,补脾益气、清热解毒,与青蒿、柴胡、黄芩配伍,共奏解表、散节、清火、祛潮热之效,调药中和,令邪气散去而正气无伤,助五脏热气更快、更充分的排出。本发明中的各味中药以苦寒清热为主,通过对药性及用量的斟酌,使各味中药相互配合协调、增进疗效、又分工明确,从而使药效直达病灶,能够快速退烧,又不引起任何副作用,能达到久而不犯;且经过该中药治疗后,一个季度内不仅感冒发烧很难再犯,且其他潜在的上火病症也得到了杜绝预防。
具体实施方式
现结合具体实施方式对本发明作进一步的解释说明。
实施例1
取柴胡30g,生甘草5g,黄芩10g,连翘40g,青蒿15g,用水冲洗干净,加水煎煮4次,每次煎煮加入原料药总重量5倍的水,煎煮15分钟,合并4次的煎液,经过滤去渣装包,即得到汤剂。
实施例2
取柴胡50g,生甘草15g,黄芩25g,连翘60g,青蒿45g,用水冲洗干净,加水煎煮3次,每次煎煮加入原料药总重量8倍的水,煎煮20分钟,合并3次的煎液,经过滤去渣经浓缩成相对密度为1.30(50℃)的稠膏,干燥、粉碎成细粉,装入胶囊中制成胶囊剂。
实施例3
取柴胡40g,生甘草10g,黄芩15g,连翘50g,青蒿30g,用水冲洗干净,加水煎煮4次,每次煎煮加入原料药总重量12倍的水,煎煮18分钟,合并2次的煎液,经过滤去渣经浓缩成相对密度为1.15(50℃)的稠膏,干燥、粉碎成细粉,添加冻干粉得到针剂。
实施例4
取柴胡40g,生甘草15g,黄芩15g,连翘55g,青蒿35g,用水冲洗干净,加水煎煮3次,每次煎煮加入原料药总重量6倍的水,煎煮15分钟,合并3次的煎液,经过滤去渣经浓缩成相对密度为1.25(50℃)的稠膏,干燥、粉碎成细粉,添加制丸剂的常规辅料得到丸剂。
实施例5
取柴胡40g,生甘草13g,黄芩20g,连翘52g,青蒿38g,用水冲洗干净,加水煎煮2次,每次煎煮加入原料药总重量9倍的水,煎煮20分钟,合并2次的煎液,经过滤去渣经浓缩成相对密度为1.20(50℃)的稠膏,干燥、粉碎成细粉,添加制片剂的常规辅料得到片剂。
为了进一步考察本发明退烧药的临床疗效,选择400例感冒发热患者进行了临床疗效观察。
1.病例资料
观察病例共400例,患者为某中医研究院的门诊和住院处患者,将其随机单盲分为(1)普通感冒治疗组、(2)普通感冒对照组、(3)流行感冒治疗组、(4)流行感冒对照组四组,每组各100人,年龄2~76岁。其中,(1)普通感冒治疗组中未成年32例,成年68例,平均年龄为33.9岁,病程1天~6天,平均2天;(2)普通感冒对照组中未成年33例,成年67例,平均年龄34岁,病程1~6天,平均1.8天;(3)流行感冒治疗组中未成年30例,成年70例,病程1~12天,平均3.4天;(4)流行感冒对照组中未成年35例,成年65例,平均年龄32岁,病程1~11天,平均2.9天。(1)和(2)、(3)和(4)中患者在年龄、病程、病情严重程度上无明显差异,具有可比性。
2.诊断标准
感冒分为狭义和广义之分,狭义上指普通感冒,是一种轻微的上呼吸道(鼻及喉部)病毒性感染,广义上还包括流行性感冒,一般比普通感冒更严重,额外的症状包括发热、冷颤及肌肉酸痛,全身性症状较明显,潜伏期1~3天不等,病程4~14天。中医认为感冒病系外感风邪,客于肺卫,以鼻塞流涕、喷嚏、咽痒或痛、咳嗽、恶寒发热、无汗或少汗、头痛、肢体酸楚为主要临床表现,四时皆有,以冬春季节为多见。
3.治疗方法。
3.1治疗组:(1)和(3)治疗组给予中医疗法,服用本发明的汤剂或胶囊剂,汤剂:每剂100mL,每3~6小时服用一次,每次100 mL;胶囊剂:每粒胶囊含本发明中药粉0.12g,每日早、晚2次,每次2~6粒,忌食辛、辣、酸、冷、油腻、酒茶等;1~6天将得到显著改善,用量可根据患者年龄、体重、所治疗的疾病的类型和严重程度等做适当调整。
3.2对照组:(2)和(4)对照组给予常规的治疗,如伪麻黄碱、马来酸氯苯那敏(扑尔敏)、对乙酰氨基酚(扑热息痛)、氢溴酸右美沙芬片(氢溴酸右美沙芬片)等口服药品,异丙托溴铵(溴化异丙托品)喷雾剂等,忌食辛、辣、酸、冷、油腻、酒茶等;用量可根据患者年龄、体重、所治疗的疾病的类型和严重程度等做适当调整。
4.疗效标准及治疗结果。
4.1标准 参照《临床疾病诊断依据治愈好转标准》确定如下标准:治愈标准为体温恢复正常,鼻子通气正常,咽喉舒服无痰,头痛、咳嗽、肢体酸楚症状消失;有效标准为体温正常,鼻塞、喷嚏、咽痒或痛、头痛、肢体酸楚、咳嗽等症状明显减轻;无效标准为体温居高不下,鼻塞、喷嚏、咽痒或痛、头痛、肢体酸楚、咳嗽等症状无明显改善或加重。
4.2患者疗效比较,见表1。
由表1可见,(1)普通感冒治疗组中,治愈90例,有效9例,无效1例,总有效率99%;(2)普通感冒对照组中,治愈52例,有效20例,无效28例,总有效率72%;(3)流行感冒治疗组中,治愈82例,有效16例,无效2例,总有效率98%;(4)流行感冒对照组中,治愈28例,有效31例,无效41例,总有效率59%。
表1 两组患者疗效比较。
组别 | 治愈 | 有效 | 无效 | 总有效率 |
普通感冒治疗组(100) | 90 | 9 | 1 | 99% |
普通感冒对照组(100) | 52 | 20 | 28 | 72% |
流行感冒治疗组(100) | 82 | 16 | 2 | 98% |
流行感冒对照组(100) | 28 | 31 | 41 | 59% |
4.3安全性指标观察
可见,本发明的药物比传统疗法对发烧的治疗效果更佳,疗程短,几近零复发,且不存在副作用,患者依从性好,对普通感冒治疗的总有效率可高达99%,对流行感冒的总有效率可高达98%,具有实际的临床意义。
Claims (7)
1.一种退烧药,其特征在于它是由以下重量配比的原料制成的药剂:柴胡6~10,生甘草1~3,黄芩2~5,连翘8~12,青蒿3~9。
2.如权利要求1所述的退烧药,其特征在于其中各原料的重量配比是:柴胡8,生甘草2,黄芩3,连翘10,青蒿6。
3.如权利要求1或2所述的退烧药,其特征在于所述的药剂是任何一种药剂学上所说的剂型。
4.如权利要求3所述的退烧药,其特征在于所述药剂是汤剂。
5.如权利要求3所述的退烧药,其特征在于所述药剂是片剂、丸剂、散剂、胶囊剂、针剂中的一种或多种。
6.如权利要求4所述的退烧药的制备方法,其特征在于包括如下步骤:
(1)将上述重量配比的各原料药,用水清洗干净;
(2)加水煎煮2~4次,每次煎煮加入原料药总重量5~12倍的水,煎煮15~20分钟,合并每次的煎液,经过滤去渣装包得到汤剂。
7.如权利要求5所述的退烧药的制备方法,其特征在于包括如下步骤:
(1)将上述重量配比的各原料药,用水清洗干净;
(2)加水煎煮2~4次,每次煎煮加入原料药总重量5~12倍的水,煎煮15~20分钟,合并每次的煎液,经过滤去渣浓缩成相对密度为1.15~1.30的稠膏,干燥、粉碎成细粉,制成片剂、丸剂、散剂、胶囊剂、针剂中的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410716229.5A CN104435133A (zh) | 2014-12-02 | 2014-12-02 | 一种退烧药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410716229.5A CN104435133A (zh) | 2014-12-02 | 2014-12-02 | 一种退烧药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104435133A true CN104435133A (zh) | 2015-03-25 |
Family
ID=52882395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410716229.5A Pending CN104435133A (zh) | 2014-12-02 | 2014-12-02 | 一种退烧药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435133A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843184A (zh) * | 2020-12-10 | 2021-05-28 | 石门县中医医院 | 一种治疗风热感冒的药物组合物及其应用 |
-
2014
- 2014-12-02 CN CN201410716229.5A patent/CN104435133A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843184A (zh) * | 2020-12-10 | 2021-05-28 | 石门县中医医院 | 一种治疗风热感冒的药物组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547496B (zh) | 一种润肺止咳的中药组合物及其制备方法 | |
CN103977314A (zh) | 一种治疗呼吸道疾病的药物组合物及制备方法和用途 | |
CN103585401A (zh) | 一种治疗禽流感的中药组合物及其制备方法 | |
CN102139051B (zh) | 清热解毒软胶囊在制备用于治疗病毒性肺炎药物中的应用 | |
CN104147194B (zh) | 一种治疗慢性鼻窦炎的中药组合物 | |
CN103479978B (zh) | 一种驱蛔的中药组合物及其制备方法 | |
CN103977370A (zh) | 一种具有利水消肿作用的药物组合物 | |
CN103463340B (zh) | 一种治疗偏头痛的中药制剂 | |
CN104435133A (zh) | 一种退烧药 | |
CN104398670A (zh) | 通过清肺热除肺毒治疗脂溢性脱发的中药制剂 | |
CN104173830A (zh) | 冬季感冒高烧解表和里药剂及制备方法 | |
CN103463444B (zh) | 一种治疗痰瘀交阻型痤疮的中药组合物 | |
CN105250746A (zh) | 一种清热解毒口服液及其制备方法 | |
CN105395879A (zh) | 一种治疗老年慢性支气管炎的中药 | |
CN105079580A (zh) | 一种治疗风温肺热病的中药组合物 | |
CN104474173A (zh) | 一种治疗面神经麻痹的药物 | |
CN103948783A (zh) | 一种预防和/或治疗脑梗塞的药物组合物 | |
CN103301354B (zh) | 一种治疗婴幼儿阴道炎的散剂制备方法 | |
CN104587035A (zh) | 一种治疗口腔溃疡的药物组合物及其制备方法 | |
CN103316258B (zh) | 一种治疗婴幼儿阴道炎的药物组合物 | |
CN111491648A (zh) | 一种中药组合物及其制备方法以及应用 | |
CN110694034A (zh) | 一种治疗感冒的中成药及其制备方法 | |
CN102886008A (zh) | 一种具有退热止咳功效的中药制剂 | |
CN107823424A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN103599446A (zh) | 一种具有退热止咳功效的中药口服液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
RJ01 | Rejection of invention patent application after publication |